Select cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transport

Free Radical Biology and Medicine

Volumn 47, Issue 6, 2009, Pages 722-730

  Brechbuhl, Heather M ^a   Min, Elysia ^b   Kariya, Chirag ^a   Frederick, Barbara ^a   Raben, David ^a   Day, Brian J ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

15 Deoxy 12,14 prostaglandin J2; ATP binding cassette transporter proteins; Breast cancer resistance protein; Free radicals; Glutathione; Prostaglandins

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; BREAST CANCER RESISTANCE PROTEIN; GLUTATHIONE; HOE 33342; ICOSANOID; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN J2; RNA DIRECTED DNA POLYMERASE; TERT BUTYL HYDROPEROXIDE;

ARTICLE; CELL LINE; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; GLUTATHIONE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN TRANSPORT; WESTERN BLOTTING;

ATP-BINDING CASSETTE TRANSPORTERS; BENZIMIDAZOLES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOPROTECTION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PROSTAGLANDIN D2; RESPIRATORY MUCOSA; SUBSTRATE SPECIFICITY; TERT-BUTYLHYDROPEROXIDE;

EID: 68349146410     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.06.005     Document Type: Article

References (66)

1. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
2. Molloy E.S., and McCarthy G.M. Eicosanoids, osteoarthritis, and crystal deposition diseases. Curr. Opin. Rheumatol. 17 (2005) 346-350
3. Park G.Y., and Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol., Lung Cell. Mol. Physiol. 290 (2006) L797-805
4. Wang M.T., Honn K.V., and Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 26 (2007) 525-534
5. Hao C.M., and Breyer M.D. Physiological regulation of prostaglandins in the kidney. Annu. Rev. Physiol. 70 (2008) 357-377
6. Santangelo F. Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach. Curr. Med. Chem. 10 (2003) 2599-2610
7. Moriarty-Craige S.E., and Jones D.P. Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 24 (2004) 481-509
8. Rahman I., and Adcock I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 28 (2006) 219-242
9. Kim E.H., and Surh Y.J. 15-Deoxy-Δ12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem. Pharmacol. 72 (2006) 1516-1528
10. Carrasco E., Casper D., and Werner P. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. J. Neurosci. Res. 85 (2007) 3109-3117
11. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., and Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378 (2004) 373-382
12. Oh J.Y., Giles N., Landar A., and Darley-Usmar V. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem. J. 411 (2008) 297-306
13. Liang X., Wang Q., Hand T., Wu L., Breyer R.M., Montine T.J., and Andreasson K. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J. Neurosci. 25 (2005) 10180-10187
14. Joy A.P., and Cowley E.A. 8-Iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor. Am. J. Respir. Cell Mol. Biol. 38 (2008) 143-152
15. Musiek E.S., Gao L., Milne G.L., Han W., Everhart M.B., Wang D., Backlund M.G., DuBois R.N., Zanoni G., Vidari G., Blackwell T.S., and Morrow J.D. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J. Biol. Chem. 280 (2005) 35562-35570
16. Dickinson D.A., and Forman H.J. Glutathione in defense and signaling: lessons from a small thiol. Ann. N. Y. Acad. Sci. 973 (2002) 488-504
17. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84
18. Wild A.C., Moinova H.R., and Mulcahy R.T. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 274 (1999) 33627-33636
19. Lyakhovich V.V., Vavilin V.A., Zenkov N.K., and Menshchikova E.B. Active defense under oxidative stress: the antioxidant responsive element. Biochemistry (Moscow) 71 (2006) 962-974
20. Day B.J., van Heeckeren A.M., Min E., and Velsor L.W. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Infect. Immun. 72 (2004) 2045-2051
21. Cantin A.M., North S.L., Hubbard R.C., and Crystal R.G. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63 (1987) 152-157
22. Mao Q., Deeley R.G., and Cole S.P. Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles. J. Biol. Chem. 275 (2000) 34166-34172
23. Hagmann W., Nies A.T., Konig J., Frey M., Zentgraf H., and Keppler D. Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase. Eur. J. Biochem. 265 (1999) 281-289
24. Zelcer N., Saeki T., Reid G., Beijnen J.H., and Borst P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276 (2001) 46400-46407
25. Rius M., Nies A.T., Hummel-Eisenbeiss J., Jedlitschky G., and Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38 (2003) 374-384
26. Sadzuka Y., Sugiyama T., Suzuki T., and Sonobe T. Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol. Lett. 123 (2001) 159-167
27. Kogan I., Ramjeesingh M., Li C., Kidd J.F., Wang Y., Leslie E.M., Cole S.P., and Bear C.E. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J. 22 (2003) 1981-1989
28. Reid G., Wielinga P., Zelcer N., van der Heijden I., Kuil A., de Haas M., Wijnholds J., and Borst P. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 100 (2003) 9244-9249
29. Paumi C.M., Wright M., Townsend A.J., and Morrow C.S. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Biochemistry 42 (2003) 5429-5437
30. Homem de Bittencourt Jr. P.I., and Curi R. Antiproliferative prostaglandins and the MRP/GS-X pump role in cancer immunosuppression and insight into new strategies in cancer gene therapy. Biochem. Pharmacol. 62 (2001) 811-819
31. Gayarre J., Stamatakis K., Renedo M., and Perez-Sala D. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. FEBS Lett. 579 (2005) 5803-5808
32. Lim S.Y., Jang J.H., Na H.K., Lu S.C., Rahman I., and Surh Y.J. 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. J. Biol. Chem. 279 (2004) 46263-46270
33. Saito Y., Nishio K., Numakawa Y., Ogawa Y., Yoshida Y., Noguchi N., and Niki E. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. J. Neurochem. 102 (2007) 1625-1634
34. Smith T.K., Ikeda Y., Fujii J., Taniguchi N., and Meister A. Different sites of acivicin binding and inactivation of gamma-glutamyl transpeptidases. Proc. Natl. Acad. Sci. USA 92 (1995) 2360-2364
35. Velsor L.W., Kariya C., Kachadourian R., and Day B.J. Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am. J. Respir. Cell Mol. Biol. 35 (2006) 579-586
36. Straus D.S., and Glass C.K. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21 (2001) 185-210
37. Sanchez-Gomez F.J., Cernuda-Morollon E., Stamatakis K., and Perez-Sala D. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol. Pharmacol. 66 (2004) 1349-1358
38. Hooijberg J.H., Peters G.J., Kaspers G.J., Wielinga P.R., Veerman A.J., Pieters R., and Jansen G. Online fluorescent method to assess BCRP/ABCG2 activity in suspension cells. Nucleosides Nucleotides Nucleic Acids 23 (2004) 1451-1454
39. Doyle L.A., and Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 (2003) 7340-7358
40. Levonen A.L., Dickinson D.A., Moellering D.R., Mulcahy R.T., Forman H.J., and Darley-Usmar V.M. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1846-1851
41. Qin S., McLaughlin A.P., and De Vries G.W. Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. Invest. Ophthalmol. Visual Sci. 47 (2006) 5098-5105
42. Telakowski-Hopkins C.A., King R.G., and Pickett C.B. Glutathione S-transferase Ya subunit gene: identification of regulatory elements required for basal level and inducible expression. Proc. Natl. Acad. Sci. USA 85 (1988) 1000-1004
43. Moinova H.R., and Mulcahy R.T. Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem. Biophys. Res. Commun. 261 (1999) 661-668
44. Jeyapaul J., and Jaiswal A.K. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem. Pharmacol. 59 (2000) 1433-1439
45. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., Wolf C.R., Cavin C., and Hayes J.D. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61 (2001) 3299-3307
46. Lee J.M., and Johnson J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J. Biochem. Mol. Biol. 37 (2004) 139-143
47. Cantin A.M., Hubbard R.C., and Crystal R.G. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139 (1989) 370-372
48. Roum J.H., Buhl R., McElvaney N.G., Borok Z., and Crystal R.G. Systemic deficiency of glutathione in cystic fibrosis. J. Appl. Physiol. 75 (1993) 2419-2424
49. Pacht E.R., Timerman A.P., Lykens M.G., and Merola A.J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100 (1991) 1397-1403
50. Pacht E.R., Diaz P., Clanton T., Hart J., and Gadek J.E. Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time. Chest 112 (1997) 785-788
51. Mochizuki M., Ishii Y., Itoh K., Iizuka T., Morishima Y., Kimura T., Kiwamoto T., Matsuno Y., Hegab A.E., Nomura A., Sakamoto T., Uchida K., Yamamoto M., and Sekizawa K. Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am. J. Respir. Crit. Care Med. 171 (2005) 1260-1266
52. Leitner H.M., Kachadourian R., and Day B.J. Harnessing drug resistance: using ABC transporter proteins to target cancer cells. Biochem. Pharmacol. 74 (2007) 1677-1685
53. Juliano R.L., and Ling V.A. surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455 (1976) 152-162
54. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51 (1991) 794-798
55. Laurent A., Nicco C., Chereau C., Goulvestre C., Alexandre J., Alves A., Levy E., Goldwasser F., Panis Y., Soubrane O., Weill B., and Batteux F. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 65 (2005) 948-956
56. Nicco C., Laurent A., Chereau C., Weill B., and Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed. Pharmacother. 59 (2005) 169-174
57. Summer R., Kotton D.N., Sun X., Ma B., Fitzsimmons K., and Fine A. Side population cells and Bcrp1 expression in lung. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L97-104
58. Scheffer G.L., Pijnenborg A.C., Smit E.F., Muller M., Postma D.S., Timens W., van der Valk P., de Vries E.G., and Scheper R.J. Multidrug resistance related molecules in human and murine lung. J. Clin. Pathol. 55 (2002) 332-339
59. van der Deen M., de Vries E.G., Timens W., Scheper R.J., Timmer-Bosscha H., and Postma D.S. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir. Res. 6 (2005) 59
60. Huls M., Brown C.D., Windass A.S., Sayer R., van den Heuvel J.J., Heemskerk S., Russel F.G., and Masereeuw R. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 73 (2008) 220-225
61. Ahmed F., Arseni N., Glimm H., Hiddemann W., Buske C., and Feuring-Buske M. Constitutive expression of the ATP-binding cassette transporter ABCG2 enhances the growth potential of early human hematopoietic progenitors. Stem Cells 26 (2008) 810-818
62. Aye I.L., Paxton J.W., Evseenko D.A., and Keelan J.A. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta 28 (2007) 868-877
63. Yeboah D., Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., and Gibb W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can. J. Physiol. Pharmacol. 84 (2006) 1251-1258
64. Urquhart B.L., Ware J.A., Tirona R.G., Ho R.H., Leake B.F., Schwarz U.I., Zaher H., Palandra J., Gregor J.C., Dresser G.K., and Kim R.B. Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Pharmacogenet. Genomics 18 (2008) 439-448
65. Kusuhara H., and Sugiyama Y. Active efflux across the blood-brain barrier: role of the solute carrier family. NeuroRx 2 (2005) 73-85
66. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 20 (2002) 11-20